Skip to main content

and
  1. No Access

    Article

    Spironolactone prevents the osteopenic effect of hypoestrogenism induced by GNRH-agonist administration

    S. Adami, N. Zambelian, D. Ganti, M. Rossini, V. Braga in Osteoporosis International (1996)